Charles Explorer logo
🇨🇿

Rituximab v udržovací léčbě ANCA asociované vaskulitidy

Publikace na 1. lékařská fakulta |
2023

Abstrakt

Souhrn s komentářem. Citace: Delestre F, Charles P, Karras A, et al.

Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials. Ann Rheum Dis 2023 Nov 2:ard-2023-224623. doi: 10.1136/ard-2023-224623.

Epub ahead of print.